{
    "nct_id": "NCT03243331",
    "official_title": "An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer",
    "inclusion_criteria": "* Metastatic Triple-negative Breast Cancer\n* Willingness to undergo tumor biopsy\n* Patients must have received at least 1 prior chemotherapy regimen for metastatic disease\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous treatment with mTOR inhibitor\n* Untreated brain metastases",
    "miscellaneous_criteria": ""
}